Friday, July 31, 2026

Washington D.C. Hosts Groundbreaking Industrial Summit with U.S., Japan, and South Korea

The industrial ministers of South Korea, the...

TXT’s Yeonjun Makes History: First Korean Artist to Perform at Z100 Summer Bash 2026!

Yeonjun of Tomorrow X Together will perform at Z100's Summer Bash, marking a historic moment for Korean artists in the U.S. music scene.

How Hanmi’s e-Label Service is Revolutionizing Drug Information Access for Patients

Hanmi Pharmaceutical launches an e-label service for medications, enhancing access to drug info while promoting sustainability.

Tag: Growth

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

D&D Pharmatech signs $1.24 million obesity drug research deal with Pfizer

D&D Pharmatech partners with Pfizer for a $1.24M obesity treatment project, marking a significant revenue milestone for the company.

2026 PRP Kit Revolution: How Humedix and Medisarang Are Transforming Regenerative Medicine

Humedics and Medisarang partner to develop regenerative medicine devices, focusing on PRP kits for aesthetics and other medical fields.

Truxima: How the First Korean Biosimilar Achieved 35.8% Market Share in the U.S.!

Celltrion’s Truxima becomes South Korea's first biosimilar to lead U.S. prescription market, boosted by tariff exemptions and strong growth.

How Dr. Ville is Revolutionizing Medical Knowledge Sharing for 40,000+ Doctors in 2026

Dr. Ville expands as a physician platform, offering relevant content and support, surpassing 40,000 members with significant growth in engagement.

Stoboclo: How This New Osteoporosis Treatment Achieved 11.8 Billion KRW in Sales in Just One Year

Daewoong Pharmaceutical's Stoboclo, a biosimilar for osteoporosis, achieved 11.8 billion KRW in sales in its first year, marking rapid growth.

Drug Price Reform Plan Prompts Emergency Meeting by South Korean Pharma Group

The Korea Pharmaceutical and Bio-Pharma Association plans strategies to address the new drug price reform and improve the industry.

How Celltrion’s Local Production Strategy Eliminates U.S. Drug Tariffs Influence

Celltrion resolves tariff impacts on U.S. sales, boosting local production and growth opportunities for its biosimilars, including Zymfentra.

Boehringer Ingelheim’s People Promise: How HR Innovation is Shaping the Future of Work in Asia

Boehringer Ingelheim emphasizes a people-centered strategy, focusing on talent mobility, leadership development, and diversity in the Asia-Pacific region.

Samsung Biologics America Achieves Record Profit: What This Means for Global Expansion in 2026

Samsung Biologics America reports record profits, showcasing its successful global expansion strategy despite previous revenue dips.

Unlock YouTube Earnings: New 500 Subscriber Requirement for Shopping Program

YouTube lowers eligibility for its Partner Program to 500 subscribers, enabling creators to earn commissions from tagged products.

2026 Senior Care Market: CareLabs’ Bold New Venture Explained

CareLabs CEO Lee Min-kyung announces plans to enter the senior care market, leveraging digital healthcare for growth and innovation.

Lotte Biologics Wins CDMO Leadership Award… Validates “Quality Management”

Lotte Biologics wins "Best New or Relaunched CDMO" at the 2026 CDMO Leadership Awards, showcasing rapid growth and global recognition.

CGBio Reports Return to Operating Profit in 2025… Growth in Bone Substitutes and Dental Business

CGBio Co., Ltd. reported a $2.6M operating profit in 2025, reversing losses and achieving 36% revenue growth, driven by bone substitutes.

How Zymfentra’s Prescription Rates Tripled in January: A Game-Changer for Celltrion

Celltrion's Zymfentra sees a 213% rise in U.S. prescriptions, marking significant growth since its launch, driven by market demand.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.